GENEVA, Sept. 18 -- SANYOU BIOPHARMACEUTICAL (SHANGHAI) CO., LTD filed a patent application (CN2025/120960) for “5T4-TARGETING ANTIBODY AND USE THEREOF”. With publication no. WO/2026/184053, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C07K 19/00
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....